Tandem Diabetes Care (TNDM) EBITDA Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn | 146.00 |
| 10 | Tandem Diabetes Care | 1.26 Bn | 806.56 Mn | 144.78 Mn | 1,611.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,611.00 |
| Mar 31, 2026 | 4,451.00 |
| Dec 31, 2025 | 306.00 |
| Sep 30, 2025 | 152.00 |
| Jun 30, 2025 | -766.00 |
| Mar 31, 2025 | -2,982.00 |
| Dec 31, 2024 | 1,761.00 |
| Sep 30, 2024 | 630.00 |
| Jun 30, 2024 | 594.00 |
| Mar 31, 2024 | 5,372.00 |
| Dec 31, 2023 | -975.00 |
| Sep 30, 2023 | 622.00 |
| Jun 30, 2023 | -1,370.00 |
| Mar 31, 2023 | -6,674.00 |
| Dec 31, 2022 | -1,413.00 |
| Sep 30, 2022 | -2,752.00 |
| Jun 30, 2022 | -927.00 |
| Mar 31, 2022 | -642.00 |
| Dec 31, 2021 | -504.00 |
| Sep 30, 2021 | 511.00 |